Abbott Laboratories (ABT), the global healthcare titan, announced on Dec. 22 that the U.S. Food and Drug Administration (FDA) has approved its Volt™ PFA System for treating atrial fibrillation (AFib).
Shoulder Innovations' revenue guidance was raised to $45.5M for 2025, with Q3 sales up 58% YoY and sequential growth expected ...
Calvert-Lewin’s is by far the smallest, represented by the shaded black area. The list is dominated by target-man strikers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback